<DOC>
	<DOC>NCT02387619</DOC>
	<brief_summary>A randomized, open-label, multiple-dose, crossover study to investigate the pharmacokinetic drug interaction between rosuvastatin and telmisartan/amlodipine in healthy male volunteers</brief_summary>
	<brief_title>The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine</brief_title>
	<detailed_description>A randomized, open-label, 2-treatment, 2-sequence, 2-period, multiple-dose, crossover design</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>19~55 years healthy male Body weight is over 55kg, The result of Body Mass Index(BMI) is not less than 18 kg/m2 , no more than 27 kg/m2 Subjects who agree to keep contraceptive methods during the clinical trial. Subjects who are allergic to investigational drug. Subjects who have a medical history which can affect the clinical trial. Hypertension(Systolic BP ≥ 150mmHG or Diastolic BP ≥ 100mmHg), Hypotension(Systolic BP ≤ 100mmHg or Diastolic BP ≤ 65mmHg) Liver enzyme (AST, ALT) level exceeds the maximum normal range more than one and a half times.</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>